1. Home
  2. WFRD vs PCVX Comparison

WFRD vs PCVX Comparison

Compare WFRD & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weatherford International plc

WFRD

Weatherford International plc

SELL

Current Price

$84.65

Market Cap

6.4B

Sector

Industrials

ML Signal

SELL

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

SELL

Current Price

$61.62

Market Cap

7.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
WFRD
PCVX
Founded
1941
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
7.0B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
WFRD
PCVX
Price
$84.65
$61.62
Analyst Decision
Buy
Strong Buy
Analyst Count
12
11
Target Price
$112.33
★ $116.40
AVG Volume (30 Days)
1.1M
★ 1.8M
Earning Date
10-20-2026
11-04-2026
Dividend Yield
★ 1.27%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 3.70
N/A
Revenue
★ $4,331,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.27
N/A
P/E Ratio
$23.21
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$68.49
$42.40
52 Week High
$113.15
$90.75

Technical Indicators

Market Signals
Indicator
WFRD
PCVX
Relative Strength Index (RSI) 48.51 47.18
Support Level $80.08 $58.85
Resistance Level $85.84 $62.44
Average True Range (ATR) 3.21 2.97
MACD -0.24 -0.03
Stochastic Oscillator 26.95 26.56

Price Performance

Historical Comparison
WFRD
PCVX

About WFRD Weatherford International plc

Weatherford provides oilfield services and equipment to national, integrated, public, and private oil and gas operators. It operates across multiple upstream markets, including offshore, the rest of the world onshore, and US onshore, where Weatherford has limited exposure. The Middle East, North Africa, and Asia account for nearly 40% of sales. Weatherford also offers manufacturing, research, and training services. Weatherford reports performance through three segments: drilling and evaluation, well construction and completions, and production and intervention.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: